Harald Nusser

Harald Nusser, Ph.D., MBA, has been leading Novartis Access since June 2015. Since October 2016, he has also taken on the responsibility for the Novartis Malaria Initiative, the Novartis Healthy Family programs, SMS for Life and NGO supply which have been combined with Novartis Access into a newly formed unit called Novartis Social Business. Dr. Nusser started his career at Schering AG in 2000 as a mathematician in the global R&D function. Having worked in both exploratory research as well as clinical research, he held positions of increasing responsibility between 2004 and 2010 in Corporate Strategy and Strategic Planning in both Schering AG and as of 2006 in Bayer. As Head of Portfolio Management, he managed the Holistic R&D Portfolio Review for Bayer Pharma and the annual Strategic Planning Process for Bayer HealthCare, led restructuring activities and became Managing Director for Bayer spol. s r.o. in Slovakia in 2010. Starting in 2012, Dr. Nusser led the Bayer HealthCare business (comprising Animal Health, Radiology, Diabetes Care, OTC and Pharmaceuticals) in Sub-Saharan Africa, Uruguay, Paraguay, Bolivia, Peru, Laos, Myanmar and Cambodia before joining Sandoz International, the Novartis generics and biosimilars division, in June 2015 as Global Head, Novartis Access. Dr. Nusser is a member of the Novartis Access to Medicines Committee. He graduated with a Ph.D. in mathematics from the Free University of Berlin in 1998 and with a MBA from the University of Bradford, UK in 2003.